The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
Open accessAbstract
Classical Hodgkin lymphomas (cHLs) contain small numbers of neoplastic Reed–Sternberg (RS) cells within an extensive inflammatory infiltrate that includes abundant T helper (Th)-2 and T regulatory (T reg ) cells. The skewed nature of the T cell infiltrate and the lack of an effective host antitumor immune response suggest that RS cells use potent mechanisms to evade immune attack. In a screen for T cell-inhibitory molecules in cHL, we found that RS cells selectively overexpressed the immunoregulatory glycan-binding protein, galectin-1 (Gal1), through an AP1-dependent enhancer. In cocultures of activated T cells and Hodgkin cell lines, RNAi-mediated blockade of RS cell Gal1 increased T cell viability and restored the Th1/Th2 balance. In contrast, Gal1 treatment of activated T cells favored the secretion of Th2 cytokines and the expansion of CD4 + CD25 high FOXP3 + T reg cells. These data directly implicate RS cell Gal1 in the development and maintenance of an immunosuppressive Th2/T reg -skewed microenvironment in cHL and provide the molecular basis for selective Gal1 expression in RS cells. Thus, Gal1 represents a potential therapeutic target for restoring immune surveillance in cHL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the false discovery rate in behavior genetics research
Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N., & Golani, I. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00297-2 · Cited by 4,146
Identifying differentially expressed genes using false discovery rate controlling procedures
Reiner, A., Yekutieli, D., & Benjamini, Y. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btf877 · Cited by 1,765
Galectins as modulators of tumour progression
Liu, F.-T., & Rabinovich, G. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1527 · Cited by 1,439
Self-citationApoptosis of T cells mediated by galectin-1
Perillo, N. L., Pace, K. E., Seilhamer, J. J., & Baum, L. G. (1995) · Nature · doi:10.1038/378736a0 · Cited by 1,074
Monti, S. (2005) · Blood · doi:10.1182/blood-2004-07-2947 · Cited by 820
Self-citationKanzler, H., Küppers, R., Hansmann, M. L., & Rajewsky, K. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1495 · Cited by 742
Zorn, E., Nelson, E. A., Mohseni, M., Porcheray, F., Kim, H., Litsa, D., Bellucci, R., Raderschall, E., Canning, C., Soiffer, R. J., et al. (2006) · Blood · doi:10.1182/blood-2006-02-004747 · Cited by 740
Toscano, M. A., Bianco, G. A., Ilarregui, J. M., Croci, D. O., Correale, J., Hernandez, J. D., Zwirner, N. W., Poirier, F., Riley, E. M., Baum, L. G., et al. (2007) · Nature Immunology · doi:10.1038/ni1482 · Cited by 653
Self-citationGalectin-1: a key effector of regulation mediated by CD4+CD25+ T cells
Garín, M. I., Chu, C.-C., Golshayan, D., Cernuda-Morollón, E., Wait, R., & Lechler, R. I. (2007) · Blood · doi:10.1182/blood-2006-04-016451 · Cited by 542
Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?
Rabinovich, G. A., Baum, L. G., Tinari, N., Paganelli, R., Natoli, C., Liu, F.-T., & Iacobelli, S. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02232-9 · Cited by 533
Self-citationRubinstein, N., Alvarez, M., Zwirner, N. W., Toscano, M. A., Ilarregui, J. M., Bravo, A., Mordoh, J., Fainboim, L., Podhajcer, O. L., & Rabinovich, G. A. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00024-8 · Cited by 531
Self-citationImmunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma
Marshall, N. A., Christie, L. E., Munro, L. R., Culligan, D. J., Johnston, P. W., Barker, R. N., & Vickers, M. A. (2004) · Blood · doi:10.1182/blood-2003-07-2594 · Cited by 509
Galectin-3 and Galectin-1 Bind Distinct Cell Surface Glycoprotein Receptors to Induce T Cell Death
Stillman, B. N., Hsu, D. K., Pang, M., Brewer, C. F., Johnson, P., Liu, F.-T., & Baum, L. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.778 · Cited by 507
Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy
Thijssen, V. L. J. L., Postel, R., Brandwijk, R. J. M. G. E., Dings, R. P. M., Nesmelova, I., Satijn, S., Verhofstad, N., Nakabeppu, Y., Baum, L. G., Bakkers, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603883103 · Cited by 497
rVISTA 2.0: evolutionary analysis of transcription factor binding sites
Loots, G. G., & Ovcharenko, I. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh383 · Cited by 412
Mathas, S., Hinz, M., Anagnostopoulos, I., Krappmann, D., Lietz, A., Jundt, F., Bommert, K., Mechta‐Grigoriou, F., Stein, H., Dörken, B., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf389 · Cited by 375
Rabinovich, G. A., Daly, G., Dreja, H., Tailor, H., Riera, C. M., Hirabayashi, J., & Chernajovsky, Y. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.385 · Cited by 360
Self-citationsiRNA Selection Server: an automated siRNA oligonucleotide prediction server
Yuan, B., Latek, R., Hossbach, M., Tuschl, T., & Lewitter, F. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh366 · Cited by 307
Ishida, T., Ishii, T., Inagaki, A., Yano, H., Komatsu, H., Iida, S., Inagaki, H., & Ueda, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0261 · Cited by 291
Scherf, M., Klingenhoff, A., & Werner, T. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3589 · Cited by 280
Galectin-1: A Link Between Tumor Hypoxia and Tumor Immune Privilege
Le, Q.-T., Shi, G., Cao, H., Nelson, D. W., Wang, Y., Chen, E. Y., Zhao, S., Kong, C., Richardson, D., O'Byrne, K. J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0206 · Cited by 258
Galectin-1 suppresses experimental colitis in mice
Santucci, L., Fiorucci, S., Rubinstein, N., Mencarelli, A., Palazzetti, B., Federici, B., Rabinovich, G. A., & Morelli, A. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00267-1 · Cited by 256
Self-citationGandhi, M. K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J., & Khanna, R. (2006) · Blood · doi:10.1182/blood-2006-04-015164 · Cited by 255
Galectin-1 as a potential cancer target
Rabinovich, G. A. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602493 · Cited by 240
Self-citationVasta, G. R., Ahmed, H., & Odom, E. W. (2004) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2004.09.008 · Cited by 235
Amano, M., Galvan, M., He, J., & Baum, L. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209595200 · Cited by 212
Abramson, J. S., & Shipp, M. A. (2005) · Blood · doi:10.1182/blood-2005-02-0687 · Cited by 208
Self-citationCamby, I., Belot, N., Lefranc, F., Sadeghi, N., de Launoit, Y., Kaltner, H., Musette, S., Darro, F., Danguy, A., Salmon, I., et al. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.7.585 · Cited by 205
Toscano, M. A., Commodaro, A. G., Ilarregui, J. M., Bianco, G. A., Liberman, A., Serra, H. M., Hirabayashi, J., Rizzo, L. V., & Rabinovich, G. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6323 · Cited by 198
Self-citationPresentation of Galectin-1 by Extracellular Matrix Triggers T Cell Death
He, J., & Baum, L. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311183200 · Cited by 191
von Wasielewski, R., Seth, S., Franklin, J., Fischer, R., Hübner, K., Hansmann, M. L., Diehl, V., & Georgii, A. (2000) · Blood · doi:10.1182/blood.v95.4.1207.004k34_1207_1213 · Cited by 191
Gandhi, M. K., Moll, G., Smith, C., Dua, U., Lambley, E., Ramuz, O., Gill, D., Marlton, P., Seymour, J. F., & Khanna, R. (2007) · Blood · doi:10.1182/blood-2007-01-066100 · Cited by 165
Smith, P. G., Wang, F., Wilkinson, K., Savage, K. J. J., Klein, U., Neuberg, D. S., Bollag, G. E., Shipp, M. A., & Aguiar, R. C. T. (2004) · Blood · doi:10.1182/blood-2004-01-0240 · Cited by 144
Self-citationPolo, J. M., Juszczyński, P., Monti, S., Cerchietti, L. C. A., Ye, K. Q., Greally, J. M., Shipp, M. A., & Melnick, A. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611399104 · Cited by 137
Self-citationAmelioration of graft versus host disease by galectin-1
Baum, L. G., Blackall, D. P., Arias-Magallano, S., Nanigian, D., Uh, S. Y., Browne, J. M., Hoffmann, D., Emmanouilides, C. E., Territo, M., & Baldwin, G. C. (2003) · Clinical Immunology · doi:10.1016/j.clim.2003.08.003 · Cited by 135
Juszczyński, P., Kutok, J. L., Li, C., Mitra, J., Aguiar, R. C. T., & Shipp, M. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02351-05 · Cited by 128
Self-citationStrongly enhanced IL-10 production using stable galectin-1 homodimers
van der Leij, J., van den Berg, A., Harms, G., Eschbach, H., Vos, H. J., Zwiers, P. J., van Weeghel, R., Groen, H., Poppema, S., & Visser, L. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.02.011 · Cited by 111
The Role of Interleukin 13 in Classical Hodgkin Lymphoma
Skinnider, B., Kapp, U., & Mak, T. W. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290026259 · Cited by 88
Jenner, J., Kerst, G., Handgretinger, R., & Müller, I. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.04.016 · Cited by 81
Improving specificity of DNA hybridization-based methods
Chalaya, T. V. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh125 · Cited by 80
AP-1 blockade inhibits the growth of normal and malignant breast cells
Ludes-Meyers, J. H., Liu, Y., Munoz‐Medellin, D., Hilsenbeck, S. G., & Brown, P. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204377 · Cited by 65
Salvatore, P., Benvenuto, G., Caporaso, M., Bruni, C. B., & Chiariotti, L. (1998) · FEBS Letters · doi:10.1016/s0014-5793(97)01553-6 · Cited by 24
Medicare Part D: early findings on enrollment and choices for rural beneficiaries.
McBride, T. D., Terry, T. L., & Mueller, K. J. (2006) · PubMed · Cited by 23
Gabrilovich, D. I. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780006850 · Cited by 18
Gabrilovich, D. I. (2007) · Current Cancer Drug Targets · doi:10.2174/1568009610707010001 · Cited by 17
Research works printed but not linked: 6
- 10.1200/JCO.2005.55.013 · DOI
- 10.1093/annonc/13.S1.11 · doi:10.1093/annonc/13.s1.11
- 10.1182/blood-2002-03-0839 · DOI
- DI Gabrilovich Curr Cancer Drug Targets 7, 1 (2007).
- J van der Leij, A van den Berg, G Harms, H Eschbach, H Vos, P Zwiers, R van Weeghel, H Groen, S Poppema, L Visser Mol Immunol 10, 1–8 (2006).
- MA Toscano, GA Bianco, JM Ilarregui, DO Croci, J Correale, JD Hernandez, NW Zwirner, F Poirier, EM Riley, LG Baum, et al. Nat Immunol, 10.1038/ni 1482. (2007). · doi:10.1038/ni
Cited by
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Ansell, S. M., Lesokhin, A. M., Borrello, I., Halwani, A., Scott, E. C., Gutierrez, M., Schuster, S. J., Millenson, M. M., Cattry, D., Freeman, G. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411087 · Cited by 3,560
Self-citationGreen, M. R., Monti, S., Rodig, S. J., Juszczynski, P., Currie, T., O'Donnell, E., Chapuy, B., Takeyama, K., Neuberg, D., Golub, T. R., et al. (2010) · Blood · doi:10.1182/blood-2010-05-282780 · Cited by 1,305
Self-citationTurning 'sweet' on immunity: galectin–glycan interactions in immune tolerance and inflammation
Rabinovich, G. A., & Toscano, M. A. (2009) · Nature Reviews Immunology · doi:10.1038/nri2536 · Cited by 904
Self-citationGalectins: structure, function and therapeutic potential
Yang, R.-Y., Rabinovich, G. A., & Liu, F.-T. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000719 · Cited by 862
Self-citationChen, B. J., Chapuy, B., Ouyang, J., Sun, H. H., Roemer, M. G. M., Xu, M. L., Yu, H., Fletcher, C. D. M., Freeman, G. J., Shipp, M. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0855 · Cited by 843
Self-citation
Metadata
- Authors
- Juszczynski, P., Ouyang, J., Monti, S., Rodig, S. J., Takeyama, K., Abramson, J., Chen, W., Kutok, J. L., Rabinovich, G. A., & Shipp, M. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-08-07
- Volume
- 104
- Issue
- 32
- Pages
- 13134-13139
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2027907558
- Cited by
- 327
- References
- 46
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.